drugset / Trial / NCT07256756
A Study of GC203 TIL in Advanced Solid Tumors (NF)
Phase 1
Not yet recruiting
8 enrolled
Shanghai Juncell Therapeutics
Shenzhen Hospital of Southern Medical University · collab
NaSingle-groupOpen-labelTreatment
Summary
This study is a prospective, open-label, single-arm clinical trial aimed at evaluating the safety and efficacy of GC203 TIL therapy in treating malignant solid tumors that have failed standard treatment.
Timeline
- Start
- 2026-01-30
- Primary completion
- 2026-11-30
- Completion
- 2028-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GC203 TIL | Cell therapy | — | — |
Indications
No indication recorded.